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Post-MI Risk Stratification: EF, TWA, SAECG, HRT, or BRS?
The REFINE (Risk Estimation Following Infarction, Noninvasive Evaluation)study compared several modalities to identify patients at risk of serious events
post-myocardial infarction (MI). Over 300 patients with ST-segment elevation MI
and an ejection fraction (EF)50%were enrolled and studied at 3weeks and12weeks
post-MI. Studies performed included exercise and resting T-wave alternans (TWA)
testing, signal-averaged electrocardiography (SAECG), phenylephrine-induced
baroreflex sensitivity (BRS) testing, heart rate variability, and heart rate turbulence
(HRT). Testing at 3 weeks was not useful, whereas testing at 10 to 14 weeks was. The
20% of patients with impaired HRT, abnormal exercise TWA, and an EF 0.50
beyond 8 weeks post-MI were 5 times more likely to die, with a negative predictive
value of 95%. See page 2275.
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Post-Infarction Risk
Baroreflex Sensitivity Predicts Long-Term Cardiovascular Mortality
Baroreflex sensitivity (BRS) is themagnitude of the change in theheart rate inducedby a transient increase in blood pressure; it is measured by giving subjects
intravenous boluses of phenylephrine and then measuring changes in heart rate and
blood pressure. De Ferrari and colleagues postulated that reduced BRS would identify
post-myocardial infarction (MI) patients at increased risk for death. Patients who
survived a ST-segment elevation MI and had an ejection fraction35% underwent
BRS testing 4 weeks post-MI and were then followed for 5 years. Cardiovascular
mortality amongpatientswith depressedBRS (3ms/mmHg)was 26%compared to
2.4% in those with normal BRS, a relative risk of 11.4. A depressed BRS suggests that
sympathetic activity is increased and/or unopposed by adequate vagal activity and
identifies patients at high risk for death. See page 2285. See figure.
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Invasive Cardiology
Novel Technique Allows Measurement of Coronary Artery Flow
Aarnoudse and colleagues describe a method for volumetric measurement ofcoronary flow using the principles of thermodilution and a guidewire with a
temperature probe. Flow can bemeasured anywhere the guidewire can be placed. This
system was tested in dogs, where flow could be measured accurately, and then in
humans, where measurements were compared with fractional flow reserve. This
technique for directmeasurement of blood flow in select coronary segments appears to
be fairly simple to perform and provides reliable information. See page 2294. See
figure.
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Preclinical Studies
Evidence for Active Apoptosis in Atherosclerotic Lesions
Apoptosis of macrophages and smooth muscle cells may lead to plaque rupture;caspase enzymes are key modulators of apoptosis. Sarai and colleagues studied
whether caspase inhibitors would reduce apoptosis in a rabbitmodel of atherosclerosis.
Caspase inhibitors or placebo were infused prior to imaging with technetium-labeled
annexin A5, which binds to cells undergoing apoptosis. There was significantly less
uptake in animals that had received caspase inhibitors, confirming both the presence of
apoptosis in these lesions and its reduction with caspase inhibitors. This study demon-
strates that molecular imaging can be used to quantify the rate of apoptosis in
atherosclerotic lesions and that this rate can be reduced by infusing caspase inhibitors.
See page 2305. See figure.
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From Around the World
Dearth of Cardiovascular Research From Developing Countries
Prabhakaran and colleagues studied the number and quality of cardiovasculardisease (CVD) research publications from developing countries. A 55% increase
in disability-adjusted life-year loss attributable to CVD in developing countries is
projected between 1990 and 2020 by the Global Burden of Disease Study. This is
primarily due to increasing rates of obesity and diabetes. Nevertheless, 82% of CVD-
relatedpublicationswere fromhigh-income countries (HICandHMIC), compared to
only 7% in lowmiddle- (LMIC), and 4% in low-income countries (LIC). There were
no studies related to health systemorganization, cost effectiveness, or quality of care for
CVD in LIC countries. This study suggests that there is a large unmet need for studies
addressing health care delivery systems andmodifiers ofCVD in the developingworld.
See page 2322. See figure.
